These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 23847928)
1. [Research progress in tumor-suppressor gene methylation of hepatocellular carcinoma]. Dai H; Liu NZ; Zuo GQ Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):143-6. PubMed ID: 23847928 [No Abstract] [Full Text] [Related]
2. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062 [TBL] [Abstract][Full Text] [Related]
4. Methylation of nucleolar and coiled-body phosphoprotein 1 is associated with the mechanism of tumorigenesis in hepatocellular carcinoma. Duan X; Zhang J; Liu S; Zhang M; Wang Q; Cheng J Oncol Rep; 2013 Nov; 30(5):2220-8. PubMed ID: 23970161 [TBL] [Abstract][Full Text] [Related]
5. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors. Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900 [TBL] [Abstract][Full Text] [Related]
7. [Relationship between DNA methylation and expressions of p57kip2 in hepatocellular carcinoma]. Zhao JZ; Zhang ZJ; Shen LJ; Cheng RC; Zhang HX; Qian ZY Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):703-4. PubMed ID: 19785964 [No Abstract] [Full Text] [Related]
8. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma. Cheng Y; Zhang C; Zhao J; Wang C; Xu Y; Han Z; Jiang G; Guo X; Li R; Bu X; Wu M; Wei L Exp Mol Pathol; 2010 Feb; 88(1):112-7. PubMed ID: 19879258 [TBL] [Abstract][Full Text] [Related]
9. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines]. Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987 [TBL] [Abstract][Full Text] [Related]
10. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070 [TBL] [Abstract][Full Text] [Related]
11. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447 [TBL] [Abstract][Full Text] [Related]
12. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
13. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India. Kiran M; Chawla YK; Kaur J Cancer Genet Cytogenet; 2009 Dec; 195(2):112-9. PubMed ID: 19963110 [TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Park HJ; Yu E; Shim YH Cancer Lett; 2006 Feb; 233(2):271-8. PubMed ID: 15885882 [TBL] [Abstract][Full Text] [Related]
15. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
16. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma. Nishida N; Nishimura T; Nakai T; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Inoue T; Minami Y; Ueshima K; Sakurai T; Kudo M Dig Dis; 2014; 32(6):658-63. PubMed ID: 25376281 [TBL] [Abstract][Full Text] [Related]
18. [The effect and clinical significance of methylation of 14-3-3 sigma gene in hepatitis B virus-related hepatocellular carcinoma]. Gao YF; Su Q; Li JB; Wei SF; Li X Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):144-5. PubMed ID: 20196956 [No Abstract] [Full Text] [Related]
19. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643 [TBL] [Abstract][Full Text] [Related]
20. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]